Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Koski

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Neurology|February 1, 1997
Subarachnoid hemorrhage in a patient with Lyme diseaseM Chehrenama, M T Zagardo, C L Koski
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1985
Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixationC L Koski, R Humphrey, M L Shin
Neuroreport|July 23, 1998
Regional differences in the effects of task difficulty and motor output on blood flow response in the human anterior cingulate cortex: a review of 107 PET activation studiesT Paus, L Koski, Z Caramanos, et al.
Glia|August 1, 1997
Dibutyryl cyclic AMP and inflammatory cytokines mediate C3 expression in Schwann cellsS M Dashiell, P Vanguri, C L Koski
Glia|March 17, 2000
Terminal complement complexes concomitantly stimulate proliferation and rescue of Schwann cells from apoptosisS M Dashiell, H Rus, C L Koski
Journal of Neuroimmunology|January 1, 1994
Antibody of patients with Guillain-Barré syndrome mediates complement-dependent cytolysis of rat Schwann cells: susceptibility to cytolysis reflects Schwann cell phenotypeS Sawant-Mane, A Estep, C L Koski
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1985
Activation of the alternative pathway of complement by human peripheral nerve myelinC L Koski, P Vanguri, M L Shin
Annals of Neurology|April 1, 1991
In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexesS Sawant-Mane, M B Clark, C L Koski
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1985
Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9D F Carney, C L Koski, M L Shin
The Journal of Clinical Investigation|July 1, 1989
Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigenC L Koski, D K Chou, F B Jungalwala
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Neurology|February 1, 1997
Subarachnoid hemorrhage in a patient with Lyme diseaseM Chehrenama, M T Zagardo, C L Koski
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1985
Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixationC L Koski, R Humphrey, M L Shin
Neuroreport|July 23, 1998
Regional differences in the effects of task difficulty and motor output on blood flow response in the human anterior cingulate cortex: a review of 107 PET activation studiesT Paus, L Koski, Z Caramanos, et al.
Glia|August 1, 1997
Dibutyryl cyclic AMP and inflammatory cytokines mediate C3 expression in Schwann cellsS M Dashiell, P Vanguri, C L Koski
Glia|March 17, 2000
Terminal complement complexes concomitantly stimulate proliferation and rescue of Schwann cells from apoptosisS M Dashiell, H Rus, C L Koski
Journal of Neuroimmunology|January 1, 1994
Antibody of patients with Guillain-Barré syndrome mediates complement-dependent cytolysis of rat Schwann cells: susceptibility to cytolysis reflects Schwann cell phenotypeS Sawant-Mane, A Estep, C L Koski
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1985
Activation of the alternative pathway of complement by human peripheral nerve myelinC L Koski, P Vanguri, M L Shin
Annals of Neurology|April 1, 1991
In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexesS Sawant-Mane, M B Clark, C L Koski
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1985
Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9D F Carney, C L Koski, M L Shin
The Journal of Clinical Investigation|July 1, 1989
Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigenC L Koski, D K Chou, F B Jungalwala
Pageof 7